-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NyBmcj8Ar1JxsoNzjYEWK2dIv/zcBdi887IuV9VJxrbr95+eiaEkWG7bkW5IpSVH c24DZ28Mrz/3xz6kohxNPw== 0001369714-09-000004.txt : 20090817 0001369714-09-000004.hdr.sgml : 20090817 20090814203855 ACCESSION NUMBER: 0001369714-09-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090817 DATE AS OF CHANGE: 20090814 EFFECTIVENESS DATE: 20090817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REVASCULAR THERAPEUTICS INC CENTRAL INDEX KEY: 0001369714 IRS NUMBER: 770510584 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-92148 FILM NUMBER: 091017759 BUSINESS ADDRESS: STREET 1: 766 PALOMAR AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 408-617-0770 MAIL ADDRESS: STREET 1: 766 PALOMAR AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 D/A 1 primary_doc.xml X0502 D/A LIVE 0001369714 REVASCULAR THERAPEUTICS INC 766 PALOMAR AVE SUNNYVALE CA 94085 408-617-0770 Norborn Medical, Inc. DELAWARE Corporation true Tom Palermo c/o Revascular Therapeutics, Inc. 766 Palomar Avenue Sunnyvale CA 94085 Executive Officer Director A. Barr Dolan c/o Charter Life Sciences, L.P. 525 University Ave., Suite 1400 Palo Alto CA 94301 Director Peter Fitzgerald c/o Revascular Therapeutics, Inc. 766 Palomar Avenue Sunnyvale CA 94085 Director Michael Lynn c/o Adams Street Partners, LLC One North Wacker, Suite 2200 Chicago IL 60606-2823 Director Steve Salmon c/o Latterell Venture Partners One Embarcadero Center San Francisco CA 94111 Director Carl Simpson c/o Revascular Therapeutics, Inc. 766 Palomar Avenue Sunnyvale CA 94085 Director Other Decline to Disclose 06 true 0001369714-09-000003 2008-06-27 false true false 0 4499795 3986086 513709 Total Offering Amount: $4,499,794.80, Total Amount Sold: $3,986,085.60, Total Remaining to be sold: $513,709.20 false 6 0 0 0 false REVASCULAR THERAPEUTICS INC J. CASEY MCGLYNN J. CASEY MCGLYNN SECRETARY 2009-08-14 -----END PRIVACY-ENHANCED MESSAGE-----